Patients and methods
icella-zoster virus (VZV) and cytomegalovirus are of major
Human thyroid cells infected with VZV (Oka-strain) served importance. The incidence of HZ has been described in up as antigen. The detection limit was determined as an antito 50% of post-transplant patients.
2 While selective antibody titre of 1:10 in preliminary tests. Seroconversion was viral drugs are available for treatment, the prophylactic use defined as a titre of у1:10 in previously negative patients. of live attenuated varicella vaccines has so far been A у4-fold increase in antibody titre was considered controversial.
significant. The object of this study was to show the effect of active To determine the incidence and clinical course of VZV immunization using a live attenuated varicella vaccine infections, 133 non-immunized children who had received (Varilrix) in preventing varicella-zoster (VZ) disease in BM transplants (59 autologous and 74 allogeneic) were also children after BMT. To verify the success of the vaccistudied. The mean age was 7 years. The follow-up period nation, virus-specific antibodies were measured. The inciextended over 32 months after BMT. HZ was defined as dence of VZV infections was determined retrospectively in the occurrence of vesicular rash beginning in the typical a group of un-immunized children who had received bone dermatological distribution. The incidence of HZ was marrow (BM) transplants.
determined by the Kaplan-Meier method.
varicella to susceptible persons coming in contact with a Discussion vaccinee was not observed.
The kinetics of post-vaccination antibody titres are VZV infections are one of the most common complications shown in Table 1 . Four weeks before administration of vacafter BMT. Our results are consistent with the reported incicine no VZV-specific IgG antibodies could be found in any dence of HZ in BMT patients of 23-50%. 2,4-7 HZ often of the 15 prospective vaccinees. At the time of vaccination becomes generalized. This justifies increased efforts to nine patients were still seronegative, six children had titres improve treatment and prophylaxis. between 1:10 and 1:80. Three of the seropositive children Antiviral agents (acyclovir, valaciclovir, famciclovir, had developed local HZ in the time between BMT and brivudin) are available to treat HZ. The nucleoside triphosadministration of vaccine.
phates of these drugs inhibit viral DNA polymerase only After immunization, eight of the nine seronegative chilin virus-infected cells when used in therapeutic doses. Most dren seroconverted within 6 months, 6 within the first six of these drugs have the obvious advantage of being effecweeks. One patient (No. 5) seronegative for 12 months sertive when given orally (brivudin, valaciclovir, famciclovir). oconverted after a second dose of vaccine 6 months later.
Passive immunization with VZ immunoglobulins is an In three vaccinees a significant increase in titre was found effective method of post-exposure prophylaxis of varicella within 6 months. Antibody titres remained unchanged or when given within 72 h of exposure and prevents severe decreased within the first year in three patients whose anti-VZ disease in immunosuppressed patients. 8 Hyperimmunobody titres were all between 1:20 and 1:80 measured at the globulins are unsuitable for long-term prophylaxis against time of immunization. Vaccine-induced antibodies per-HZ because of their short half-lives. sisted for at least 24 months in six seroconverted children, Active immunization must be considered the most effecthree having become seronegative at that time.
tive method of long-term prophylaxis against VZV infecOf the non-immunized 133 children, 32 developed HZ tions. After the Oka-strain was attenuated by Takahashi and disease within the observation period of 32 months after coworkers, 9 the immunogenic efficacy of VZV vaccines BMT (16 autologous and 16 allogeneic transplant licensed in Europe and the USA was tested several times, receivers). The HZ was limited to one dermatome area in both in healthy and immunocompromised patients as well most cases. Recurrences were observed in three patients.
as in patients during antineoplastic chemotherapy. 10,11 As Three patients had generalised HZ but definite discrimihigh seroconversion rates could be achieved in these nation from secondary varicella disease was not possible.
patients without major adverse reactions, investigation of The cumulative incidence of VZV infections was 26.3%. the protective action of varicella vaccine in children who HZ occurred usually within the first 3 months after BMT had received BM transplants seemed appropriate. with a median of approximately 6 months, irrespective of Our results show a high seroconversion rate (eight out the type of transplant.
of nine cases) in vaccinated children post BMT comparable Most patients who developed HZ were treated with acyto the findings in immunosuppressed children with leuclovir (30 mg/kg/day) for 5 to 10 days; in one case brivudin kaemia. 12 Additionally, in three children a significant was given at 15 mg/kg/day. None of the patients died as a increase in titre was measured. A period of 6 weeks, although common in vaccine studies, is probably too short result of the HZ disease. to study the immune response for these severely immunoshould be reserved for cases of VZ disease occurring prior to vaccine-induced immunity. suppressed patients; one-third of our cases seroconverted only within 6 months.
Three of the 15 vaccinees showed no humoral immune References response to varicella vaccine. It was possibe that the vac- up to 2 years, they were undetectable in three out of 15
